Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- Check3 days agoChange DetectedRecruitment status on the study page now indicates no participants are being enrolled. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling along with a new revision tag.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page revision label was updated to v3.5.5. This indicates a minor update to the page's metadata or formatting.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.4 indicates a new build of the ClinicalTrials.gov interface. This is a routine release update and does not modify the listed study details or eligibility criteria.SummaryDifference0.1%

- Check54 days agoChange DetectedThe ClinicalTrials.gov page footer was updated to a new software/site revision version (from v3.5.2 to v3.5.3). This reflects a site/version update rather than any change to the study record information.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.